In addition, front‐line SCT did not appear to result in any differential benefit in OS between races (HRs for death were similar between races and did not reach statistical significance in either group) [ 26 ].
← all excerpts
Real-world multiple myeloma front-line treatment and outcomes by transplant in the United States.
1
—
—